This blue biotechnology startup explores microbial communities in extreme marine environments to discover novel enzymes and biomolecules. They apply sustainable bioprospecting techniques to develop new industrial applications and products from these unique deep-sea microbes.
Funding
Funding not disclosed
Founders
Product
Problem
The discovery of novel enzymes and biomolecules for industrial applications is often limited by the accessibility and diversity of explored environments. Traditional methods of bioprospecting can be invasive and inefficient in characterizing the complex microbial communities of extreme marine ecosystems.
Solution
Nautigen employs sustainable bioprospecting techniques to explore microbial communities in extreme marine environments, such as cold seeps, hydrothermal vents, and abyssal seafloor settings, to discover novel enzymes and biomolecules. The company utilizes non-invasive, advanced biomolecular and remote sensing technologies to rapidly detect, map, characterize, and catalog the deep marine microbiome. Nautigen visualizes biodiversity of marine extremophiles using digital twin technology and evaluates the biotechnological potential of novel bioactive molecules in real-time and in situ. This approach facilitates transparent drug discovery pipelines and sustainable pharmaceutical applications within the Blue Economy.
Target Audience
Nautigen's primary customers are pharmaceutical companies, research institutions, and other organizations seeking novel enzymes and biomolecules for drug discovery and industrial applications.
Features
- Sustainable bioprospecting of extreme marine ecosystems
- Non-invasive, advanced biomolecular and remote sensing technologies
- Real-time, in situ evaluation of bioactive molecule potential
- Digital twin technology for visualizing marine extremophile biodiversity
- Focus on cold seeps, hydrothermal vents, and abyssal seafloor settings